Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg)

Emily Carne; Mark Ponsford; Tariq El-Shanawany; Stephen Jolles

doi:10.1007/s10875-016-0346-6

Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg)

J Clin Immunol. 2017 Jan;37(1):27-28. doi: 10.1007/s10875-016-0346-6. Epub 2016 Oct 28.

Authors

Emily Carne¹, Mark Ponsford¹, Tariq El-Shanawany¹, Stephen Jolles²

Affiliations

¹ Immunodeficiency Centre for Wales, Department of Immunology, University Hospital of Wales, Cardiff, CF14 4XW, UK.
² Immunodeficiency Centre for Wales, Department of Immunology, University Hospital of Wales, Cardiff, CF14 4XW, UK. jollessr@cardiff.ac.uk.

PMID: 27796699
DOI: 10.1007/s10875-016-0346-6

No abstract available

Keywords: Subcutaneous immunoglobulin (SCIg); facilitated subcutaneous immunoglobulin (fSCIg); primary immunodeficiency (PID) and common variable immunodeficiency (CVID); skin necrosis.

Publication types

Case Reports
Letter

MeSH terms

Adult
Autonomic Nervous System Diseases / diagnosis
Autonomic Nervous System Diseases / drug therapy*
Common Variable Immunodeficiency / diagnosis
Common Variable Immunodeficiency / drug therapy*
Drug-Related Side Effects and Adverse Reactions / diagnosis*
Female
Humans
Immunoglobulin G / adverse effects
Immunoglobulin G / therapeutic use*
Injections, Subcutaneous
Male
Middle Aged
Necrosis
Needles
Skin / drug effects
Skin / pathology*
Skin Ulcer / diagnosis*
Skin Ulcer / etiology

Substances

Immunoglobulin G

Supplementary concepts

Motor neuropathy peripheral with dysautonomia